Ziptek Introduces ZipE® Biolock™ Technology for Tissue Repair

Ziptek, an international medical device innovator, has announced growing clinical and commercial adoption of its ZipE® Biolock™ technology, a resorbable tissue repair system designed to work in harmony with the body’s natural healing process.

The technology differs from conventional anchor-based repair methods by enabling progressive fixation release that aligns with tissue regeneration timelines. 

This mechanism is intended to support tissue remodelling rather than scar-based repair, with potential application in procedures such as rotator cuff reconstruction.

ZipE® Biolock™ introduces a controlled tendon compression approach aimed at improving tissue stability during healing while reducing risks associated with traditional suture systems, including tissue damage and gapping. 

The system is designed to create a more biologically supportive environment for repair across multiple anatomical indications.

The company reports clinical experience across more than 500 surgical cases, with follow-up data extending up to four years. Early findings suggest reduced re-operation rates and improved recovery timelines compared with published benchmarks.

Ziptek holds over 28 patents and has received multiple innovation awards. The ZipE® Biolock™ system is currently approved for use in the United States and Mexico and is registered in the United Arab Emirates.